We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

Massimo D'Apuzzo,

Pathologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Pathology
Education
Medical school:
Board Certifications

  • 2006, Anatomic Pathology Board Certification

  • 2007, Neuropathology Board Certification

  • 2004, California Medical License

Degrees

  • 1997, University of Bern, Switzerland, Ph.D., Immunology

  • 1993, University of Bern, Switzerland, M.D., Medicine

Professional Experience

  • 2007 - present, Neuropathologist and Anatomic Pathologist, Department of Pathology, City of Hope, Duarte, CA

  • 2012- Neuropathologist and Anatomic Pathologist, Hoag Hospital Newport Beach, CA

  • 2004 - 2006, Neuropathology Fellow, Department of Pathology, Stanford University Medical Center, Palo Alto, CA

  • 2005 - 2006, Research Associate, Stem Cells, Department of Pathology, Stanford University Medical Center, Palo Alto, CA

  • 2002 - 2004, Anatomic Pathology Resident, Department of Pathology, Massachusetts General Hospital, Boston, MA

  • 2001 - 2002, Gastrointestinal Pathology Research Fellow, Department of Pathology, Massachusetts General Hospital, Boston, MA

  • 1998 - 2001, Postdoctoral Scholar, Neuroscience, Division of Biology, California Institute of Technology, Pasadena, CA

  • 1994 - 1997, Graduate Research, Immunology, University of Bern, Switzerland

Academic Appointments
  • Clinical Professor, Department of Pathology
About Me
Massimo D'Apuzzo, M.D., is the neuropathologist for City of Hope's Brain Tumor program. He is responsible for diagnosing the majority of brain and spinal cord cases at City of Hope.
 
Dr. D'Apuzzo earned his medical degree and a Ph.D. in immunology at the University of Bern, Switzerland. He completed further training at Cal Tech, Massachusetts General Hospital and Stanford University before joining City of Hope in 2007.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.